Skip to main content
OpenTrials

Clinical trial condition

Eczema

Explore clinical trials studying Eczema. Study availability and eligibility vary by location and protocol.

143 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Eczema trial results

Completed

A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

NCT06436183

Conditions
Atopic, Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Medical Dermatology Specialists, PC/US Dermatology Partners Phoenix, Arizona, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • First OC Dermatology Research, Inc. Fountain Valley, California, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
View all 35 locations
View Trial Details
Completed

A Community-based Assessment of Skin Care, Allergies, and Eczema

NCT03409367

Conditions
Atopic Dermatitis, Atopic Disorders, Atopic Eczema, +12 more
Locations
  • University of Colorado-Denver Denver, Colorado, United States
  • Duke University Durham, North Carolina, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • University of Wisconsin-Madison Madison, Wisconsin, United States
View Trial Details
Completed

Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study

NCT05131477

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Investigative Site Number: 1018 Fremont, California, United States
  • Investigative site #1022 Sacramento, California, United States
  • Investigative Site Number: 1006 Boca Raton, Florida, United States
  • Investigative Site Number: 1001 Clearwater, Florida, United States
View all 103 locations
View Trial Details
Completed

A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine

NCT05149313

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Alm Site 1 Graz, Austria
  • Alm Site 2 Ghent, Belgium
  • Alm Site 14 Bordeaux, France
  • Alm Site 17 Le Mans, France
View all 48 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis

NCT04021862

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Beach Clinical Research Inc Huntington Beach, California, United States
  • Florida Academic Dermatology Centers Coral Gables, Florida, United States
  • Doral Medical Research Doral, Florida, United States
  • Floridian Research Institute Miami, Florida, United States
View all 17 locations
View Trial Details

Related conditions